Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer.
Phase 3
- Conditions
- Advanced (nonresectable/recurrent) gastric cancer
- Registration Number
- JPRN-jRCT1080220046
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with nonresectable or recurrent gastric cancer which is histologically confirmed adenocarcinoma.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival and adverse events
- Secondary Outcome Measures
Name Time Method